These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 31585941)
1. A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits. Corso S; Isella C; Bellomo SE; Apicella M; Durando S; Migliore C; Ughetto S; D'Errico L; Menegon S; Moya-Rull D; Cargnelutti M; Capelôa T; Conticelli D; Giordano J; Venesio T; Balsamo A; Marchiò C; Degiuli M; Reddavid R; Fumagalli U; De Pascale S; Sgroi G; Rausa E; Baiocchi GL; Molfino S; Pietrantonio F; Morano F; Siena S; Sartore-Bianchi A; Bencivenga M; Mengardo V; Rosati R; Marrelli D; Morgagni P; Rausei S; Pallabazzer G; De Simone M; Ribero D; Marsoni S; Sottile A; Medico E; Cassoni P; Sapino A; Pectasides E; Thorner AR; Nag A; Drinan SD; Wollison BM; Bass AJ; Giordano S Cancer Res; 2019 Nov; 79(22):5884-5896. PubMed ID: 31585941 [TBL] [Abstract][Full Text] [Related]
2. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial. Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834 [TBL] [Abstract][Full Text] [Related]
3. Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer. Furukawa K; Hatakeyama K; Terashima M; Urakami K; Koseki Y; Fujiya K; Tanizawa Y; Bando E; Yamaguchi K Gastric Cancer; 2024 Jul; 27(4):760-771. PubMed ID: 38744779 [TBL] [Abstract][Full Text] [Related]
4. The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses. Kim SY; Choi YY; An JY; Shin HB; Jo A; Choi H; Seo SH; Bang HJ; Cheong JH; Hyung WJ; Noh SH Int J Cancer; 2015 Aug; 137(4):819-25. PubMed ID: 25614197 [TBL] [Abstract][Full Text] [Related]
5. KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status. Polom K; Das K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Tan P; Roviello F Pathol Oncol Res; 2019 Jan; 25(1):333-340. PubMed ID: 29116623 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer. Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305 [TBL] [Abstract][Full Text] [Related]
7. The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors. Gullo I; Carvalho J; Martins D; Lemos D; Monteiro AR; Ferreira M; Das K; Tan P; Oliveira C; Carneiro F; Oliveira P Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018250 [TBL] [Abstract][Full Text] [Related]
8. Immune-related gene signature predicts overall survival of gastric cancer patients with varying microsatellite instability status. Tian R; Hu J; Ma X; Liang L; Guo S Aging (Albany NY); 2020 Dec; 13(2):2418-2435. PubMed ID: 33316777 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of telomere function in gastric cancers with and without microsatellite instability. Pascua I; Fernández-Marcelo T; Sánchez-Pernaute A; de Juan C; Head J; Torres-García AJ; Iniesta P Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):162-9. PubMed ID: 25486025 [TBL] [Abstract][Full Text] [Related]
10. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts. Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A Cells; 2019 Jun; 8(6):. PubMed ID: 31207870 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy. Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151 [TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability in solitary and sporadic gastric cancer. Perez RO; Jacob CE; D'Ottaviano FL; Alvarenga C; Ribeiro AS; Ribeiro U; Bresciani CJ; Zilberstein B; Krieger JE; Habr-Gama A; Gama-Rodrigues JJ Rev Hosp Clin Fac Med Sao Paulo; 2004 Oct; 59(5):279-85. PubMed ID: 15543400 [TBL] [Abstract][Full Text] [Related]
13. Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer. Chen Z; Huang W; Tian T; Zang W; Wang J; Liu Z; Li Z; Lai Y; Jiang Z; Gao J; Shen L J Hematol Oncol; 2018 Feb; 11(1):20. PubMed ID: 29433585 [TBL] [Abstract][Full Text] [Related]
14. Molecular profiling and comprehensive genome-wide analysis of somatic copy number alterations in gastric intramucosal neoplasias based on microsatellite status. Sugai T; Eizuka M; Arakawa N; Osakabe M; Habano W; Fujita Y; Yamamoto E; Yamano H; Endoh M; Matsumoto T; Suzuki H Gastric Cancer; 2018 Sep; 21(5):765-775. PubMed ID: 29468422 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype. Sugimoto R; Sugai T; Habano W; Endoh M; Eizuka M; Yamamoto E; Uesugi N; Ishida K; Kawasaki T; Matsumoto T; Suzuki H Int J Cancer; 2016 Apr; 138(7):1689-97. PubMed ID: 26538087 [TBL] [Abstract][Full Text] [Related]
16. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases. Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224 [TBL] [Abstract][Full Text] [Related]
17. Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer. Marrelli D; Polom K; Pascale V; Vindigni C; Piagnerelli R; De Franco L; Ferrara F; Roviello G; Garosi L; Petrioli R; Roviello F Ann Surg Oncol; 2016 Mar; 23(3):943-50. PubMed ID: 26530444 [TBL] [Abstract][Full Text] [Related]
18. Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker. Kim JW; Im SA; Kim MA; Cho HJ; Lee DW; Lee KH; Kim TY; Han SW; Oh DY; Lee HJ; Kim TY; Yang HK; Kim WH; Bang YJ Int J Cancer; 2014 Jan; 134(1):72-80. PubMed ID: 23649938 [TBL] [Abstract][Full Text] [Related]
19. Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype. Kim TS; da Silva E; Coit DG; Tang LH Am J Surg Pathol; 2019 Jun; 43(6):851-860. PubMed ID: 30969179 [TBL] [Abstract][Full Text] [Related]
20. Microsatellite Instability and Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer: A Multicohort Study. Oh N; Kim H; Kim KM; Cheong JH; Lee J; Noh SH; Sohn TS; Choi YY; An JY Ann Surg Oncol; 2021 Dec; 28(13):8908-8915. PubMed ID: 34401986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]